PILOT DATASET / TRANSACTION REVIEW
Explore insider transactions.
New filings and insider history →
Search the pilot by company, ticker, insider or accession. Every imported transaction stays visible, including excluded securities and unresolved records.
120 transactions assessed62 filings154 calculated checkpoints
Data cutoff: 2026-11-04 12:55:26 UTC. Partial includes missing prices or horizons that have not matured. Counts are transaction rows, not independent purchase events.
120 matching transactions · Page 2 of 4
| Company / insider | Transaction date | Filing date | Reported value* | Assessment | Returns |
|---|---|---|---|---|---|
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 4,420 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 10,344 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 2,211 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 16,543.41 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 14,797.44 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 153,549.1 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 8,808 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 25,771.2 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 22,932 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 6,252 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 9,648.54 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 4,410 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 15,449 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 25,806.97 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 2,199 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 146,148.43 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 1,607,834.72 | excludedamendment review; not purchase acquisition | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 71.4 | excludedno executive or director; joint owner review | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 142.94 | excludedno executive or director; joint owner review | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 102.1 | excludedno executive or director; joint owner review | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 51.1 | excludedno executive or director; joint owner review | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 72.24 | excludednot purchase acquisition; no executive or director | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 143.36 | excludednot purchase acquisition; no executive or director | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-08-03 | 2026-08-04 | 102.3 | excludednot purchase acquisition; no executive or director | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-07-31 | 2026-08-04 | 51.65 | excludednot purchase acquisition; no executive or director | 0/14 |
| BXSYBEXIL INVESTMENT TRUSTWINMILL & CO. INC | 2026-07-27 | 2026-07-27 | 79,571 | excludedsecurity title review; no executive or director | 0/14 |
| BXSYBEXIL INVESTMENT TRUSTWINMILL & CO. INC | 2026-07-24 | 2026-07-27 | 79,571 | excludedsecurity title review; no executive or director | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-07-24 | 2026-07-28 | 92.16 | excludedno executive or director; joint owner review | 0/14 |
| NMZNUVEEN MUNICIPAL HIGH INCOME OPPORTUNITY FUNDBANK OF AMERICA CORP /DE/; MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | 2026-07-24 | 2026-07-28 | 91.62 | excludednot purchase acquisition; no executive or director | 0/14 |
| BXSYBEXIL INVESTMENT TRUSTWINMILL & CO. INC | 2026-07-23 | 2026-07-23 | 77,085 | excludedsecurity title review; no executive or director | 0/14 |
*Shares × bulk reported price, before any original-XML precision corrections; amounts may be rounded. Open a transaction to see source details. Returns exclude dividends and costs. No insider rankings or probability estimates are inferred from this pilot.